Not applicableUnknownNCT04462224What this trial is testingCreation of Home-based Asthma Real-World Measures With Mobile Health StudyWho this might be right forAsthma National Jewish Health 150
Large-scale testing (Phase 3)Study completedNCT00394368What this trial is testingEFFICACY AND TOLERABILITY OF BECLOMETHASONE DIPROPIONATE 100 µg + FORMOTEROL 6 µg pMDI VIA HFA-134a vs. FLUTICASONE 125 µg + SALMETEROL 25 µg pMDIWho this might be right forBronchial Asthma Chiesi Farmaceutici S.p.A. 180
Large-scale testing (Phase 3)Study completedNCT01508936What this trial is testingStudy to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe AsthmaWho this might be right forEosinophilic Asthma Teva Branded Pharmaceutical Products R&D, Inc. 511
Testing effectiveness (Phase 2)Study completedNCT01603277What this trial is testingEffect of KB003 in Subjects With Asthma Inadequately Controlled by CorticosteroidsWho this might be right forModerate-to-Severe Asthma Humanigen, Inc. 160
Not applicableStudy completedNCT00282516What this trial is testingAsthma In-Home Monitoring (AIM) TrialWho this might be right forMild, Moderate and Severe Persistent Asthma as Defined by NHLBI-2 Guidelines Tripler Army Medical Center 120
Not applicableUnknownNCT02489383What this trial is testingComparison Between Continuous Versus Interval Exercise Training in Asthmatic PatientsWho this might be right forAsthma University of Sao Paulo General Hospital 60
Testing effectiveness (Phase 2)Ended earlyNCT01673672What this trial is testingCYT003-QbG10, a TLR9-agonist, for Treatment of Uncontrolled Moderate to Severe Allergic AsthmaWho this might be right forModerate to Severe Allergic Asthma Cytos Biotechnology AG 365
Not applicableLooking for participantsNCT05691218What this trial is testingEarly High-flow Oxygen Therapy With nebuLized Beta-2-agonist Using a Vibrating Mesh for the Management of Moderate to Severe Asthma Exacerbation in the Emergency DepartmentWho this might be right forModerate Asthma ExacerbationSevere Asthma Exacerbation Poitiers University Hospital 60
Large-scale testing (Phase 3)Study completedNCT00109187What this trial is testingAn Extension Study of Xolair in Moderate to Severe, Persistent Asthma Patients Who Completed Study Q2143gWho this might be right forAsthma Genentech, Inc.
Not applicableStudy completedNCT00621829What this trial is testingFish Oil to Prevent Asthma Exacerbations in Patients With ALOX5 PolymorphismsWho this might be right forAsthma University of California, Davis 30
Testing effectiveness (Phase 2)Looking for participantsNCT07282886What this trial is testingVENTURI (VENTilation Using Respiratory Imaging)Who this might be right forAsthma University of Alabama at Birmingham 20
Not applicableStudy completedNCT00937066What this trial is testingCost-effectiveness Study of Symbicort as Maintenance and Reliever Therapy (SMART)Who this might be right forAsthma AstraZeneca 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07403487What this trial is testingPhase II Trial of RC1416 Injection in AsthmaWho this might be right forModerate to Severe Asthma Nanjing RegeneCore Biotech Co., Ltd. 195
Large-scale testing (Phase 3)Study completedNCT00862394What this trial is testingA Study Comparing the Efficacy and Safety of CHF 1535 (BDP +FF) Inhalation Powder, Administered Via the NEXT Inhaler, Versus CHF 1535 (BDP +FF), Administered Via a pMDI, in Moderate to Severe AsthmaWho this might be right forAsthma Chiesi Farmaceutici S.p.A. 783
Testing effectiveness (Phase 2)Study completedNCT06102005What this trial is testingDose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe AsthmaWho this might be right forAsthma Sanofi 685
Testing effectiveness (Phase 2)Study completedNCT05985694What this trial is testingAD17002 Treating Poorly Controlled, Moderate to Severe Eosinophilic AsthmaWho this might be right forEosinophilic Asthma Advagene Biopharma Co. Ltd. 40
Testing effectiveness (Phase 2)Looking for participantsNCT06977581What this trial is testingLearn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe AsthmaWho this might be right forAsthma Pfizer 252
Large-scale testing (Phase 3)Study completedNCT00565955What this trial is testingEffect of Addition of Oral Montelukast to Standard Treatment in Acute Moderate to Severe Asthma in ChildrenWho this might be right forBronchial Asthma All India Institute of Medical Sciences 116
Testing effectiveness (Phase 2)Study completedNCT00406965What this trial is testingEvaluate the Safety and Efficacy of HAE1 in Subjects With Moderate to Severe Allergic AsthmaWho this might be right forAllergic Asthma Genentech, Inc. 50
Large-scale testing (Phase 3)Study completedNCT00393952What this trial is testingNew Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe AsthmaWho this might be right forAsthma SkyePharma AG 557